Autoinflammatory & rare systemic diseases

Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry

Semin Arthritis RheumPublished Registry-based cohort study

Authors' conclusion

In conclusion, this study confirms that orbital/ocular inflammatory involvement is a common finding in VEXAS patients, especially when relapsing polychondritis is diagnosed.

Study context

Population
VEXAS syndrome patients in the international AIDA network VEXAS registry
Participants
59 patients
Outcome
Inflammatory orbital/ocular involvement during clinical history
Methodological detailsinternational AIDA network VEXAS registry
  • International AIDA network VEXAS registry

Main finding

As reported in the abstract

Inflammatory orbital/ocular involvement
Orbital/ocular inflammatory involvement
27 (45.8 %)
Periorbital edema
8 (13.6 %)
Episcleritis
5 (8.5 %)
Scleritis
5 (8.5 %)
Uveitis
4 (6.8 %)
Conjunctivitis
4 (6.8 %)
Blepharitis
3 (5.1 %)
Orbital myositis
2 (3.4 %)

Observational data: associations, not effects.

Further findings

Association between relapsing polychondritis and orbital/ocular involvement in VEXAS syndrome

Relative Risk (95 % CI)P value
Relapsing polychondritis2.37 (1.03–5.46)P = 0.048

Most frequent orbital/ocular affections

Periorbital edema
8 (13.6 %)
Episcleritis
5 (8.5 %)
Scleritis
5 (8.5 %)
Uveitis
4 (6.8 %)
Conjunctivitis
4 (6.8 %)
Blepharitis
3 (5.1 %)
Orbital myositis
2 (3.4 %)

Systemic immune-mediated disease diagnosis

Systemic immune-mediated disease
15 (55.6 %)
Relapsing polychondritis
12

Deaths in the whole cohort · median disease duration of 1.2 (IQR=5.35) years

Deaths
Six
Deaths with orbital/ocular inflammatory involvement
5 (83.3 %)

Original publication

Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry. Semin Arthritis Rheum. Published 18 March 2024. doi:10.1016/j.semarthrit.2024.152430

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.